Entities / Company
Cystic Fibrosis Foundation.
non-profit organization in the USA
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Gone quiet
No new reports in 90+ days-
Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.Some support3 reports2 developments inside
-
Foundation commits $24M for therapy development, led by David Liu and Michael P. Boyle, who is CEO of the Foundation.Some support1 report
-
Cystic Fibrosis Foundation provides up to $24 million in additional funding to Prime Medicine, Inc.Some support1 report
-
Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.Some support1 report
-
Prime Medicine, Inc. sold shares to the Cystic Fibrosis Foundation, with TD Cowen acting as joint book-running manager and filing with the SEC.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Cystic Fibrosis Foundation this week
News at the entities that move Cystic Fibrosis Foundation most-
Vertex Pharmaceuticals OperationalCRISPR Therapeutics formed a strategic partnership with Vertex Pharmaceuticals.Moves Cystic Fibrosis Foundation
Connections
The 1 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Vertex Pharmaceuticals Operational
Vertex Pharmaceuticals develops treatments that actively support the mission and focus area of the Cystic Fibrosis Foundation.
History
Events by the month they beganJune 2026
5 events- Prime Medicine, supported by the Cystic Fibrosis Foundation, achieved clinical proof-of-concept for CF treatments and plans to engage the FDA.
- Foundation commits $24M for therapy development, led by David Liu and Michael P. Boyle, who is CEO of the Foundation.
- Cystic Fibrosis Foundation provides up to $24 million in additional funding to Prime Medicine, Inc.
- Cystic Fibrosis Foundation provided $39 million in funding, while tariffs and onshoring benefit certain AI stocks.
- Prime Medicine, Inc. sold shares to the Cystic Fibrosis Foundation, with TD Cowen acting as joint book-running manager and filing with the SEC.